|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:RNGTT-TBC1D32 (FusionGDB2 ID:74690) |
Fusion Gene Summary for RNGTT-TBC1D32 |
Fusion gene summary |
Fusion gene information | Fusion gene name: RNGTT-TBC1D32 | Fusion gene ID: 74690 | Hgene | Tgene | Gene symbol | RNGTT | TBC1D32 | Gene ID | 8732 | 221322 |
Gene name | RNA guanylyltransferase and 5'-phosphatase | TBC1 domain family member 32 | |
Synonyms | CAP1A|HCE|HCE1|hCAP | BROMI|C6orf170|C6orf171 | |
Cytomap | 6q15 | 6q22.31 | |
Type of gene | protein-coding | protein-coding | |
Description | mRNA-capping enzymeHCAP1 | protein broad-mindedbroad-minded homolog | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q96NH3 | |
Ensembl transtripts involved in fusion gene | ENST00000369485, ENST00000265607, ENST00000538899, ENST00000369475, | ENST00000275159, ENST00000398212, ENST00000398197, | |
Fusion gene scores | * DoF score | 14 X 13 X 5=910 | 3 X 3 X 2=18 |
# samples | 15 | 3 | |
** MAII score | log2(15/910*10)=-2.60090404459018 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: RNGTT [Title/Abstract] AND TBC1D32 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | RNGTT(89388072)-TBC1D32(121642940), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | RNGTT-TBC1D32 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | RNGTT | GO:0006370 | 7-methylguanosine mRNA capping | 9473487 |
Hgene | RNGTT | GO:0006396 | RNA processing | 21636784 |
Fusion gene breakpoints across RNGTT (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across TBC1D32 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | UVM | TCGA-VD-A8KJ-01A | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
ChimerDB4 | UVM | TCGA-VD-A8KJ | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
Top |
Fusion Gene ORF analysis for RNGTT-TBC1D32 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000369485 | ENST00000275159 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
Frame-shift | ENST00000369485 | ENST00000398212 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
5CDS-intron | ENST00000369485 | ENST00000398197 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
Frame-shift | ENST00000265607 | ENST00000275159 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
Frame-shift | ENST00000265607 | ENST00000398212 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
5CDS-intron | ENST00000265607 | ENST00000398197 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
In-frame | ENST00000538899 | ENST00000275159 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
In-frame | ENST00000538899 | ENST00000398212 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
5CDS-intron | ENST00000538899 | ENST00000398197 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
intron-3CDS | ENST00000369475 | ENST00000275159 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
intron-3CDS | ENST00000369475 | ENST00000398212 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
intron-intron | ENST00000369475 | ENST00000398197 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000538899 | RNGTT | chr6 | 89388072 | - | ENST00000275159 | TBC1D32 | chr6 | 121642940 | - | 5812 | 1536 | 1483 | 5277 | 1264 |
ENST00000538899 | RNGTT | chr6 | 89388072 | - | ENST00000398212 | TBC1D32 | chr6 | 121642940 | - | 5155 | 1536 | 1483 | 5154 | 1224 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000538899 | ENST00000275159 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - | 0.000547554 | 0.9994524 |
ENST00000538899 | ENST00000398212 | RNGTT | chr6 | 89388072 | - | TBC1D32 | chr6 | 121642940 | - | 0.000924389 | 0.99907553 |
Top |
Fusion Genomic Features for RNGTT-TBC1D32 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for RNGTT-TBC1D32 |
Go to FGviewer for the breakpoints of chr6:89388072-chr6:121642940 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | TBC1D32 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Required for high-level Shh responses in the developing neural tube. Together with CDK20, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to Shh signaling (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000265607 | - | 13 | 15 | 195_205 | 479.0 | 575.0 | Compositional bias | Note=Asp/Glu-rich |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000369485 | - | 14 | 16 | 195_205 | 502.0 | 598.0 | Compositional bias | Note=Asp/Glu-rich |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000265607 | - | 13 | 15 | 25_183 | 479.0 | 575.0 | Domain | Tyrosine-protein phosphatase |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000369485 | - | 14 | 16 | 25_183 | 502.0 | 598.0 | Domain | Tyrosine-protein phosphatase |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000265607 | - | 13 | 15 | 343_345 | 479.0 | 575.0 | Nucleotide binding | GTP |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000265607 | - | 13 | 15 | 458_460 | 479.0 | 575.0 | Nucleotide binding | GTP |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000369485 | - | 14 | 16 | 343_345 | 502.0 | 598.0 | Nucleotide binding | GTP |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000369485 | - | 14 | 16 | 458_460 | 502.0 | 598.0 | Nucleotide binding | GTP |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000265607 | - | 13 | 15 | 1_212 | 479.0 | 575.0 | Region | Note=TPase |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000369485 | - | 14 | 16 | 1_212 | 502.0 | 598.0 | Region | Note=TPase |
Tgene | TBC1D32 | chr6:89388072 | chr6:121642940 | ENST00000275159 | 0 | 33 | 1119_1242 | 51.666666666666664 | 1299.0 | Domain | Note=Rab-GAP TBC | |
Tgene | TBC1D32 | chr6:89388072 | chr6:121642940 | ENST00000398212 | 0 | 32 | 1119_1242 | 51.666666666666664 | 1258.0 | Domain | Note=Rab-GAP TBC |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000265607 | - | 13 | 15 | 528_533 | 479.0 | 575.0 | Nucleotide binding | GTP |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000369485 | - | 14 | 16 | 528_533 | 502.0 | 598.0 | Nucleotide binding | GTP |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000265607 | - | 13 | 15 | 229_597 | 479.0 | 575.0 | Region | Note=GTase |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000369485 | - | 14 | 16 | 229_597 | 502.0 | 598.0 | Region | Note=GTase |
Top |
Fusion Gene Sequence for RNGTT-TBC1D32 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000538899_ENST00000275159_TCGA-VD-A8KJ-01A_RNGTT_chr6_89388072_-_TBC1D32_chr6_121642940_length(transcript)=5812nt_BP=1536nt GCATTGTGGGTTCTCCTGGAGCTGTGGAGTTGATCCTGAATGAAAGTGGCGCGCCGCCCCTGACGTTACCCGGATCGGAGAGGTTGGAAT TCAGATTACGGCTGCGATTCGGGTGTCTCGGACCCCGGTGTGCACCGGACCACGGGGAGGCGGCTCCAAAGGCGCGGTGAACGTTGGTGA GGGAGGGCAGCTCTGCGCAGCCCCAAGACATGGCTCACAACAAGATCCCGCCGCGGTGGCTGAACTGTCCCCGGCGCGGCCAGCCGGTGG CAGGTTAAAATGGGCTTGTTGGTGGACCTGACAAATACTTCAAGGTTCTATGACCGAAATGACATAGAAAAAGAAGGAATCAAATATATA AAACTTCAGTGTAAAGGACATGGTGAGTGCCCTACCACTGAGAATACTGAGACCTTTATTCGTCTGTGTGAGCGGTTTAATGAAAGAAAT CCACCTGAACTTATAGGTGTTCATTGTACTCATGGCTTCAATCGCACTGGTTTCCTCATATGTGCCTTTTTGGTGGAGAAAATGGATTGG AGTATCGAAGCAGCAGTTGCTACTTTTGCCCAAGCCAGACCACCAGGAATCTACAAGGGTGATTATTTGAAGGAACTTTTTCGTCGGTAT GGTGACATAGAGGAAGCACCACCCCCACCTCTATTGCCAGATTGGTGTTTTGAGGATGATGAAGACGAAGATGAGGATGAGGATGGAAAG AAGGAATCAGAACCCGGGTCAAGTGCTTCTTTTGGCAAAAGGAGAAAAGAACGGTTAAAACTGGGCGCTATTTTCTTGGAAGGTGTTACT GTTAAAGGTGTAACTCAAGTAACAACACAACCAAAGTTAGGAGAGGTACAGCAGAAGTGTCATCAATTCTGTGGCTGGGAAGGGTCTGGA TTCCCTGGAGCACAGCCTGTTTCCATGGACAAGCAAAATATTAAACTTTTAGACCTGAAGCCATACAAAGTAAGCTGGAAAGCAGATGGT ACTCGGTACATGATGTTGATTGATGGCACAAATGAAGTTTTTATGATTGATAGAGACAATTCAGTATTTCATGTTTCAAATCTGGAATTT CCATTTCGTAAAGATCTTCGTATGCATTTATCAAATACTCTCTTGGATGGCGAGATGATTATTGACAGAGTAAATGGACAGGCTGTTCCT AGATATTTGATATATGACATAATTAAATTCAATTCACAGCCCGTTGGAGATTGTGATTTTAATGTTCGTCTGCAGTGTATAGAACGAGAA ATTATAAGTCCTCGACACGAAAAAATGAAGACTGGGCTCATTGACAAAACACAGGAACCATTTAGCGTCAGAAATAAGCCGTTTTTTGAC ATCTGTACTTCAAGAAAGAAATACAAACCTGGTCGATGTGATGATATTTTGAAATGGAAGCCTCCCAGTCTGAATTCTGTGGATTTTCGT CTAAAAATAACAAGAATGGGAGGAGAAGGGTTACTTCCTCAGAATGTTGGCCTCCTGTATGTTGGAGGTTATGAAAGACCCTTTGCACAA ATCAAGCTATGAATTTGTGAAATACCTCAGGCAGCATATAGGCAACACTTTGGGTTCTATGATTGAAGAAGAAATGGAAAAATGCACATC TGATCGGAATCAGGGTGAAGAATGCGGCTATGATACAGTTGTACAGCAGGTCACTAAAAGAACTCAAGAATCTAAAGAGTACAAAGAAAT GATGCATTACCTGAAGAACATTATGATAGCTGTGGTCGAGTCTATGATTAACAAGTTTGAAGAAGATGAGACACGAAATCAAGAAAGGCA GAAAAAAATCCAAAAGGAGAAAAGCCATAGTTACCGCACAGACAATTGCTCTGATAGTGATTCATCATTGAATCAGAGTTACAAATTTTG TCAAGGAAAATTACAATTGATTTTAGACCAGTTGGATCCTGGGCAACCTAAAGAGGTGAGATATGAAGCCTTGCAAACATTATGTTCAGC TCCTCCATCTGATGTCCTCAACTGTGAAAATTGGACTACTCTCTGCGAAAAACTGACCGTGTCTCTTTCAGATCCTGATCCTGTGTTTAG TGACCGGATTTTAAAATTCTGTGCACAGACATTTTTGCTTTCTCCATTACATATGACCAAGGAAATTTATACAAGCTTAGCTAAGTATTT GGAGTCATACTTTCTTTCTAGGGAAAATCATATTCCTACTCTTTCAGCTGGTGTAGATATAACTAATCCTAATATGACTCGCTTACTTAA AAAGGTTCGTCTTCTAAATGAATATCAGAAAGAAGCTCCATCTTTCTGGATTCGTCATCCAGAGAAGTATATGGAAGAAATTGTGGAGAG TACTTTGTCCTTGTTAACAGTTAAACATAATCAAAGCCATGTTGTCTCACAAAAGATTTTGGATCCGATCTACTTTTTTGCATTAGTTGA TACCAAGGCTGTGTGGTTCAAAAAGTGGATGCATGCACATTATAGCAGAACTACAGTATTAAGACTTCTTGAAACGAAATATAAGTCTCT GGTAACTACAGCCATTCAACAGTGTGTTCAGTACTTTGAAATGTGTAAGACTAGGAAAGCTGATGAAACTTTGGGACATTCAAAGCATTG CAGAAACAAGCAGAAAACTTTCTACTACTTAGGACAAGAATTACAATATATTTATTTCATTCACTCACTGTGCCTTTTAGGAAGATTATT GATCTATAAACAAGGCAGAAAACTATTTCCTATTAAGCTGAAGAATAAAAAAGGTTTGGTATCCCTCATAGATCTGCTTGTTCTTTTTAC CCAACTTATCTATTACTCACCAAGTTGTCCAAAGATGACATCAGCTGCCCATTCAGAGAATTACTCTCCTGCAAGTATGGTGACTGAAGT TCTGTGGATACTCAGTGATCAAAAAGAATGTGCAGTGGAATGCTTATATAACAACATTGTAATAGAGACACTTCTTCAGCCTATTCACAA TTTAATGAAAGGAAATGAGGCATCTCCAAATTGCTCTGAGACAGCTTTAATTCATATAGCTGGTATTTTGGCAAGAATTGCATCTGTAGA AGAAGGGCTTATTTTACTCCTTTATGGAGCAAATATGAACTCTTCTGAAGAAAGTCCTACAGGTGCTCATATAATTGCCCAGTTTTCGAA AAAACTTCTCGATGAAGATATTTCTATATTTTCTGGATCAGAAATGTTGCCTGTGGTTAAAGGAGCTTTTATTTCTGTGTGTCGTCACAT ATATAGTACATGTGAAGGTTTGCAGGTGTTAATCACTTATAATTTGCATGAATCTATAGCAAAGGCATGGAAAAAGACAAGTTTGCTATC AGAAAGAATTCCTACTCCAGTAGAGGGTTCTGATTCTGTTTCTTCAGTAAGCCAGGAATCCCAAAACATTATGGCTTGGGAAGATAATTT GTTAGATGATTTACTACATTTTGCTGCCACCCCCAAAGGATTACTACTTCTTCAAAGAACAGGTGCTATCAATGAATGTGTGACATTTAT ATTCAATCGATATGCAAAAAAATTACAGGTCAGCAGGCATAAAAAATTTGGCTATGGAGTTTTGGTTACACGAGTGGCATCAACAGCAGC AGGTGGCATTGCACTAAAAAAGTCAGGGTTTATTAATGAACTTATAACTGAATTATGGTCCAATCTGGAATATGGAAGAGATGATGTTAG GGTAACCCATCCCAGAACTACTCCAGTGGATCCTATTGACCGAAGCTGTCAAAAGTCTTTTTTAGCACTGGTGAACTTGTTATCCTATCC TGCTATTTATGAGCTTGTAAGGAATCAAGATCTTCCTAATAAAACAGAATATTCTCTTCGTGAAGTCCCAACATGTGTTATTGATATTAT TGATAGACTTATAATTTTGAATTCTGAAGCTAAGATTCGTTCTTTATTCAACTATGAACAATCACATATCTTTGGTCTAAGGTTATTAAG TGTGATATGCTGTGATCTGGACACTCTTCTCCTGTTAGAGGCTCAGTATCAGGTATCTGAAATGTTACTAAATGCTCAAGAAGAAAATAT CTTGGAGATTTCTGAGAGCCACAGGGACTTTATAATTGATGGCTTATCAGTGGAGAGAAATCATGTTCTTGTTAGAATAAATCTTGTTGG TGGGCCATTGGAACGGATTTTGCCTCCGAGGTTACTCGAAAAGAGTGATAATCCATATCCTTGGCCAATGTTTTCATCATATCCATTGCC AAACTGCTATCTGTCAGACATTACAAGAAATGCTGGTATAAAACAAGACAATGATCTTGACAAGCTTTTATTATGCCTCAAAATATCTGA TAAACAAACTGAATGGATAGAAAACTGCCAAAGACAATTTTGCAAAATGATGAAAGCCAAACCTGATATAATCAGTGGAGAGGCCTTAAT AGAATTACTTGAAAAATTTGTGCTTCATCTCACTGAAAGCCCATCTGAATGCTACTTCCCTTCAGTGGAGTATACAGCTACTGATGCAAA TGTGAAGAATGAAAGTCTTTCATCTGTGCAGCAGCTTGGCATTAAAATGACTGTCAGGTATGGCAAATTCCTCAGTCTCTTAAAAGATGG TGCAGAAAATGATCTTACCTGGGTTTTAAAGCATTGTGAGAGATTCCTGAAACAGCAGCAAACTTCCATAAAATCTTCTCTTCTCTGCCT GCAAGGGAATTATGCTGGCCATGACTGGTTTGTATCTTCTCTGTTCATGATAATGTTGGGAGACAAAGAAAAAACATTCCAATTTCTTCA TCAATTCTCCAGGCTTCTGACTTCTGCTTTTCTTTGGTTGCCAAGGCTACATATTTCTAGTTACCTTCCTAATGACACTGTAGAATCTGG CATCCATCCAGTATATTTTTGCAGCACCCATTATATTGAAATGCTACTGAAGGCTGAGTTGCCTCTTGTGTTTTCAGCTTTTCACATGTC TGGTTTTGCACCATCACAGATTTGCCTGCAATGGATAACCCAGTGTTTTTGGAATTACTTAGATTGGATAGAAATCTGCCATTATATTGC TACTTGTGTTTTCCTTGGTCCTGATTATCAAGTGTATATCTGTATAGCTGTATTCAAACATTTACAGCAAGACATTCTACAGCACACTCA GACTCAAGATCTGCAAGTTTTCCTAAAAGAAGAAGCACTGCATGGGTTTCGAGTGAGTGATTATTTTGAATACATGGAAATTTTGGAACA AAACTACCGAACAGTGCTGCTGAGAGACATGCGGAACATTAGACTGCAGAGCACATAGATCATGAGACACACGGTTTAAATTTAGGTTTT ATTTATTTTTAAACACAGCAGGGGGGCTTGATGTTTTTCTGTGTCTGTAACAACATTTACTTTGTGAATATACATATTGTAAATACTGAG AAGTATAACGATATATTTAAGTAGGTATGAGCTCAATTTGTGAATTCATTTTTGTAAATTTGTTGTTTTGTAAGGTTATTATAGAATCAG ATCTAGCTTACTTTTAGTTCTTATTCATGTTTAAGAGTTAGTCCTGGCCAGGCGCGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAG TCTGAGGTGGGCGGATCACGAGGTCAAGAGATCGAGACCATCCTGGCCAAAATGGTGAAACCTCGTCTCTGCTAACAATACTGAAATTAG CTGGGTGCAGTGATGCGCCTGTAGTCCCTGCTACTTGGGAGGCTGAGGCAGGAGAATCGCTTGAACCCGGGAGGCGGAGGTTGCAGTGAG >In-frame_ENST00000538899_ENST00000275159_TCGA-VD-A8KJ-01A_RNGTT_chr6_89388072_-_TBC1D32_chr6_121642940_length(amino acids)=1264AA_start in transcript=1483_stop in transcript=5277 MLASCMLEVMKDPLHKSSYEFVKYLRQHIGNTLGSMIEEEMEKCTSDRNQGEECGYDTVVQQVTKRTQESKEYKEMMHYLKNIMIAVVES MINKFEEDETRNQERQKKIQKEKSHSYRTDNCSDSDSSLNQSYKFCQGKLQLILDQLDPGQPKEVRYEALQTLCSAPPSDVLNCENWTTL CEKLTVSLSDPDPVFSDRILKFCAQTFLLSPLHMTKEIYTSLAKYLESYFLSRENHIPTLSAGVDITNPNMTRLLKKVRLLNEYQKEAPS FWIRHPEKYMEEIVESTLSLLTVKHNQSHVVSQKILDPIYFFALVDTKAVWFKKWMHAHYSRTTVLRLLETKYKSLVTTAIQQCVQYFEM CKTRKADETLGHSKHCRNKQKTFYYLGQELQYIYFIHSLCLLGRLLIYKQGRKLFPIKLKNKKGLVSLIDLLVLFTQLIYYSPSCPKMTS AAHSENYSPASMVTEVLWILSDQKECAVECLYNNIVIETLLQPIHNLMKGNEASPNCSETALIHIAGILARIASVEEGLILLLYGANMNS SEESPTGAHIIAQFSKKLLDEDISIFSGSEMLPVVKGAFISVCRHIYSTCEGLQVLITYNLHESIAKAWKKTSLLSERIPTPVEGSDSVS SVSQESQNIMAWEDNLLDDLLHFAATPKGLLLLQRTGAINECVTFIFNRYAKKLQVSRHKKFGYGVLVTRVASTAAGGIALKKSGFINEL ITELWSNLEYGRDDVRVTHPRTTPVDPIDRSCQKSFLALVNLLSYPAIYELVRNQDLPNKTEYSLREVPTCVIDIIDRLIILNSEAKIRS LFNYEQSHIFGLRLLSVICCDLDTLLLLEAQYQVSEMLLNAQEENILEISESHRDFIIDGLSVERNHVLVRINLVGGPLERILPPRLLEK SDNPYPWPMFSSYPLPNCYLSDITRNAGIKQDNDLDKLLLCLKISDKQTEWIENCQRQFCKMMKAKPDIISGEALIELLEKFVLHLTESP SECYFPSVEYTATDANVKNESLSSVQQLGIKMTVRYGKFLSLLKDGAENDLTWVLKHCERFLKQQQTSIKSSLLCLQGNYAGHDWFVSSL FMIMLGDKEKTFQFLHQFSRLLTSAFLWLPRLHISSYLPNDTVESGIHPVYFCSTHYIEMLLKAELPLVFSAFHMSGFAPSQICLQWITQ CFWNYLDWIEICHYIATCVFLGPDYQVYICIAVFKHLQQDILQHTQTQDLQVFLKEEALHGFRVSDYFEYMEILEQNYRTVLLRDMRNIR -------------------------------------------------------------- >In-frame_ENST00000538899_ENST00000398212_TCGA-VD-A8KJ-01A_RNGTT_chr6_89388072_-_TBC1D32_chr6_121642940_length(transcript)=5155nt_BP=1536nt GCATTGTGGGTTCTCCTGGAGCTGTGGAGTTGATCCTGAATGAAAGTGGCGCGCCGCCCCTGACGTTACCCGGATCGGAGAGGTTGGAAT TCAGATTACGGCTGCGATTCGGGTGTCTCGGACCCCGGTGTGCACCGGACCACGGGGAGGCGGCTCCAAAGGCGCGGTGAACGTTGGTGA GGGAGGGCAGCTCTGCGCAGCCCCAAGACATGGCTCACAACAAGATCCCGCCGCGGTGGCTGAACTGTCCCCGGCGCGGCCAGCCGGTGG CAGGTTAAAATGGGCTTGTTGGTGGACCTGACAAATACTTCAAGGTTCTATGACCGAAATGACATAGAAAAAGAAGGAATCAAATATATA AAACTTCAGTGTAAAGGACATGGTGAGTGCCCTACCACTGAGAATACTGAGACCTTTATTCGTCTGTGTGAGCGGTTTAATGAAAGAAAT CCACCTGAACTTATAGGTGTTCATTGTACTCATGGCTTCAATCGCACTGGTTTCCTCATATGTGCCTTTTTGGTGGAGAAAATGGATTGG AGTATCGAAGCAGCAGTTGCTACTTTTGCCCAAGCCAGACCACCAGGAATCTACAAGGGTGATTATTTGAAGGAACTTTTTCGTCGGTAT GGTGACATAGAGGAAGCACCACCCCCACCTCTATTGCCAGATTGGTGTTTTGAGGATGATGAAGACGAAGATGAGGATGAGGATGGAAAG AAGGAATCAGAACCCGGGTCAAGTGCTTCTTTTGGCAAAAGGAGAAAAGAACGGTTAAAACTGGGCGCTATTTTCTTGGAAGGTGTTACT GTTAAAGGTGTAACTCAAGTAACAACACAACCAAAGTTAGGAGAGGTACAGCAGAAGTGTCATCAATTCTGTGGCTGGGAAGGGTCTGGA TTCCCTGGAGCACAGCCTGTTTCCATGGACAAGCAAAATATTAAACTTTTAGACCTGAAGCCATACAAAGTAAGCTGGAAAGCAGATGGT ACTCGGTACATGATGTTGATTGATGGCACAAATGAAGTTTTTATGATTGATAGAGACAATTCAGTATTTCATGTTTCAAATCTGGAATTT CCATTTCGTAAAGATCTTCGTATGCATTTATCAAATACTCTCTTGGATGGCGAGATGATTATTGACAGAGTAAATGGACAGGCTGTTCCT AGATATTTGATATATGACATAATTAAATTCAATTCACAGCCCGTTGGAGATTGTGATTTTAATGTTCGTCTGCAGTGTATAGAACGAGAA ATTATAAGTCCTCGACACGAAAAAATGAAGACTGGGCTCATTGACAAAACACAGGAACCATTTAGCGTCAGAAATAAGCCGTTTTTTGAC ATCTGTACTTCAAGAAAGAAATACAAACCTGGTCGATGTGATGATATTTTGAAATGGAAGCCTCCCAGTCTGAATTCTGTGGATTTTCGT CTAAAAATAACAAGAATGGGAGGAGAAGGGTTACTTCCTCAGAATGTTGGCCTCCTGTATGTTGGAGGTTATGAAAGACCCTTTGCACAA ATCAAGCTATGAATTTGTGAAATACCTCAGGCAGCATATAGGCAACACTTTGGGTTCTATGATTGAAGAAGAAATGGAAAAATGCACATC TGATCGGAATCAGGGTGAAGAATGCGGCTATGATACAGTTGTACAGCAGGTCACTAAAAGAACTCAAGAATCTAAAGAGTACAAAGAAAT GATGCATTACCTGAAGAACATTATGATAGCTGTGGTCGAGTCTATGATTAACAAGTTTGAAGAAGATGAGACACGAAATCAAGAAAGGCA GAAAAAAATCCAAAAGGAGAAAAGCCATAGTTACCGCACAGACAATTGCTCTGATAGTGATTCATCATTGAATCAGAGTTACAAATTTTG TCAAGGAAAATTACAATTGATTTTAGACCAGTTGGATCCTGGGCAACCTAAAGAGGTGAGATATGAAGCCTTGCAAACATTATGTTCAGC TCCTCCATCTGATGTCCTCAACTGTGAAAATTGGACTACTCTCTGCGAAAAACTGACCGTGTCTCTTTCAGATCCTGATCCTGTGTTTAG TGACCGGATTTTAAAATTCTGTGCACAGACATTTTTGCTTTCTCCATTACATATGACCAAGGAAATTTATACAAGCTTAGCTAAGTATTT GGAGTCATACTTTCTTTCTAGGGAAAATCATATTCCTACTCTTTCAGCTGGTGTAGATATAACTAATCCTAATATGACTCGCTTACTTAA AAAGGTTCGTCTTCTAAATGAATATCAGAAAGAAGCTCCATCTTTCTGGATTCGTCATCCAGAGAAGTATATGGAAGAAATTGTGGAGAG TACTTTGTCCTTGTTAACAGTTAAACATAATCAAAGCCATGTTGTCTCACAAAAGATTTTGGATCCGATCTACTTTTTTGCATTAGTTGA TACCAAGGCTGTGTGGTTCAAAAAGTGGATGCATGCACATTATAGCAGAACTACAGTATTAAGACTTCTTGAAACGAAATATAAGTCTCT GGTAACTACAGCCATTCAACAGTGTGTTCAGTACTTTGAAATGTGTAAGACTAGGAAAGCTGATGAAACTTTGGGACATTCAAAGCATTG CAGAAACAAGCAGAAAACTTTCTACTACTTAGGACAAGAATTACAATATATTTATTTCATTCACTCACTGTGCCTTTTAGGAAGATTATT GATCTATAAACAAGGCAGAAAACTATTTCCTATTAAGCTGAAGAATAAAAAAGGTTTGGTATCCCTCATAGATCTGCTTGTTCTTTTTAC CCAACTTATCTATTACTCACCAAGTTGTCCAAAGATGACATCAGCTGCCCATTCAGAGAATTACTCTCCTGCAAGTATGGTGACTGAAGT TCTGTGGATACTCAGTGATCAAAAAGAATGTGCAGTGGAATGCTTATATAACAACATTGTAATAGAGACACTTCTTCAGCCTATTCACAA TTTAATGAAAGGAAATGAGGCATCTCCAAATTGCTCTGAGACAGCTTTAATTCATATAGCTGGTATTTTGGCAAGAATTGCATCTGTAGA AGAAGGGCTTATTTTACTCCTTTATGGAGCAAATATGAACTCTTCTGAAGAAAGTCCTACAGGTGCTCATATAATTGCCCAGTTTTCGAA AAAACTTCTCGATGAAGATATTTCTATATTTTCTGGATCAGAAATGTTGCCTGTGGTTAAAGGAGCTTTTATTTCTGTGTGTCGTCACAT ATATAGTACATGTGAAGGTTTGCAGGTGTTAATCACTTATAATTTGCATGAATCTATAGCAAAGGCATGGAAAAAGACAAGTTTGCTATC AGAAAGAATTCCTACTCCAGTAGAGGGTTCTGATTCTGTTTCTTCAGTAAGCCAGGAATCCCAAAACATTATGGCTTGGGAAGATAATTT GTTAGATGATTTACTACATTTTGCTGCCACCCCCAAAGGATTACTACTTCTTCAAAGAACAGGTGCTATCAATGAATGTGTGACATTTAT ATTCAATCGATATGCAAAAAAATTACAGGTCAGCAGGCATAAAAAATTTGGCTATGGAGTTTTGGTTACACGAGTGGCATCAACAGCAGC AGGTGGCATTGCACTAAAAAAGTCAGGGTTTATTAATGAACTTATAACTGAATTATGGTCCAATCTGGAATATGGAAGAGATGATGTTAG GGTAACCCATCCCAGAACTACTCCAGTGGATCCTATTGACCGAAGCTGTCAAAAGTCTTTTTTAGCACTGGTGAACTTGTTATCCTATCC TGCTATTTATGAGCTTGTAAGGAATCAAGATCTTCCTAATAAAACAGAATATTCTCTTCGTGAAGTCCCAACATGTGTTATTGATATTAT TGATAGACTTATAATTTTGAATTCTGAAGCTAAGATTCGTTCTTTATTCAACTATGAACAATCACATATCTTTGGTCTAAGGGACTTTAT AATTGATGGCTTATCAGTGGAGAGAAATCATGTTCTTGTTAGAATAAATCTTGTTGGTGGGCCATTGGAACGGATTTTGCCTCCGAGGTT ACTCGAAAAGAGTGATAATCCATATCCTTGGCCAATGTTTTCATCATATCCATTGCCAAACTGCTATCTGTCAGACATTACAAGAAATGC TGGTATAAAACAAGACAATGATCTTGACAAGCTTTTATTATGCCTCAAAATATCTGATAAACAAACTGAATGGATAGAAAACTGCCAAAG ACAATTTTGCAAAATGATGAAAGCCAAACCTGATATAATCAGTGGAGAGGCCTTAATAGAATTACTTGAAAAATTTGTGCTTCATCTCAC TGAAAGCCCATCTGAATGCTACTTCCCTTCAGTGGAGTATACAGCTACTGATGCAAATGTGAAGAATGAAAGTCTTTCATCTGTGCAGCA GCTTGGCATTAAAATGACTGTCAGGTATGGCAAATTCCTCAGTCTCTTAAAAGATGGTGCAGAAAATGATCTTACCTGGGTTTTAAAGCA TTGTGAGAGATTCCTGAAACAGCAGCAAACTTCCATAAAATCTTCTCTTCTCTGCCTGCAAGGGAATTATGCTGGCCATGACTGGTTTGT ATCTTCTCTGTTCATGATAATGTTGGGAGACAAAGAAAAAACATTCCAATTTCTTCATCAATTCTCCAGGCTTCTGACTTCTGCTTTTCT TTGGTTGCCAAGGCTACATATTTCTAGTTACCTTCCTAATGACACTGTAGAATCTGGCATCCATCCAGTATATTTTTGCAGCACCCATTA TATTGAAATGCTACTGAAGGCTGAGTTGCCTCTTGTGTTTTCAGCTTTTCACATGTCTGGTTTTGCACCATCACAGATTTGCCTGCAATG GATAACCCAGTGTTTTTGGAATTACTTAGATTGGATAGAAATCTGCCATTATATTGCTACTTGTGTTTTCCTTGGTCCTGATTATCAAGT GTATATCTGTATAGCTGTATTCAAACATTTACAGCAAGACATTCTACAGCACACTCAGACTCAAGATCTGCAAGTTTTCCTAAAAGAAGA AGCACTGCATGGGTTTCGAGTGAGTGATTATTTTGAATACATGGAAATTTTGGAACAAAACTACCGAACAGTGCTGCTGAGAGACATGCG >In-frame_ENST00000538899_ENST00000398212_TCGA-VD-A8KJ-01A_RNGTT_chr6_89388072_-_TBC1D32_chr6_121642940_length(amino acids)=1224AA_start in transcript=1483_stop in transcript=5154 MLASCMLEVMKDPLHKSSYEFVKYLRQHIGNTLGSMIEEEMEKCTSDRNQGEECGYDTVVQQVTKRTQESKEYKEMMHYLKNIMIAVVES MINKFEEDETRNQERQKKIQKEKSHSYRTDNCSDSDSSLNQSYKFCQGKLQLILDQLDPGQPKEVRYEALQTLCSAPPSDVLNCENWTTL CEKLTVSLSDPDPVFSDRILKFCAQTFLLSPLHMTKEIYTSLAKYLESYFLSRENHIPTLSAGVDITNPNMTRLLKKVRLLNEYQKEAPS FWIRHPEKYMEEIVESTLSLLTVKHNQSHVVSQKILDPIYFFALVDTKAVWFKKWMHAHYSRTTVLRLLETKYKSLVTTAIQQCVQYFEM CKTRKADETLGHSKHCRNKQKTFYYLGQELQYIYFIHSLCLLGRLLIYKQGRKLFPIKLKNKKGLVSLIDLLVLFTQLIYYSPSCPKMTS AAHSENYSPASMVTEVLWILSDQKECAVECLYNNIVIETLLQPIHNLMKGNEASPNCSETALIHIAGILARIASVEEGLILLLYGANMNS SEESPTGAHIIAQFSKKLLDEDISIFSGSEMLPVVKGAFISVCRHIYSTCEGLQVLITYNLHESIAKAWKKTSLLSERIPTPVEGSDSVS SVSQESQNIMAWEDNLLDDLLHFAATPKGLLLLQRTGAINECVTFIFNRYAKKLQVSRHKKFGYGVLVTRVASTAAGGIALKKSGFINEL ITELWSNLEYGRDDVRVTHPRTTPVDPIDRSCQKSFLALVNLLSYPAIYELVRNQDLPNKTEYSLREVPTCVIDIIDRLIILNSEAKIRS LFNYEQSHIFGLRDFIIDGLSVERNHVLVRINLVGGPLERILPPRLLEKSDNPYPWPMFSSYPLPNCYLSDITRNAGIKQDNDLDKLLLC LKISDKQTEWIENCQRQFCKMMKAKPDIISGEALIELLEKFVLHLTESPSECYFPSVEYTATDANVKNESLSSVQQLGIKMTVRYGKFLS LLKDGAENDLTWVLKHCERFLKQQQTSIKSSLLCLQGNYAGHDWFVSSLFMIMLGDKEKTFQFLHQFSRLLTSAFLWLPRLHISSYLPND TVESGIHPVYFCSTHYIEMLLKAELPLVFSAFHMSGFAPSQICLQWITQCFWNYLDWIEICHYIATCVFLGPDYQVYICIAVFKHLQQDI -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for RNGTT-TBC1D32 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000265607 | - | 13 | 15 | 330_386 | 479.0 | 575.0 | POLR2A |
Hgene | RNGTT | chr6:89388072 | chr6:121642940 | ENST00000369485 | - | 14 | 16 | 330_386 | 502.0 | 598.0 | POLR2A |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for RNGTT-TBC1D32 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for RNGTT-TBC1D32 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | TBC1D32 | C0796102 | Orofaciodigital syndrome 9 | 1 | GENOMICS_ENGLAND |
Tgene | TBC1D32 | C1709353 | Osteofibrous Dysplasia | 1 | GENOMICS_ENGLAND |
Tgene | TBC1D32 | C4085248 | OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO | 1 | GENOMICS_ENGLAND |